Pure Global
NCT02895490

Communication Training in Promoting Employment Retention Among Cancer Patients

Using Communication Training to Promote Employment Retention Among Cancer Survivors
Virginia Commonwealth University·ClinicalTrials.gov·otherTerminated
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Unspecified Adult Solid Tumor, Protocol Specific
Drug/Device/Intervention
educational intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Virginia Commonwealth University
Location
Richmond, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2014
End date
Oct 01, 2015
Enrollment
8 participants
Primary outcome

Changes in perceived self-efficacy pre-intervention and post-intervention.,Compare requested pre-intervention measures to received post-intervention measures.,Compare longitudinal changes in knowledge scale before and after combination information and communication skills training.

Summary

This randomized clinical trial studies communication training in promoting employment
 retention among cancer patients. Communication training may improve patient-employer
 communication and increase the likelihood that cancer patients will remain employed, reduce
 patients' time away from work, and increase workplace accommodations that enable patients to
 balance treatment and work.

ICD-10 classifications
Carcinoma in situ, unspecifiedMalignant neoplasm, without specification of siteMalignant neoplasm, primary site unspecifiedCarcinoma in situ of other and unspecified genital organsMalignant neoplasm: Connective and soft tissue, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02895490
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT02895490 through Pure Global AI's free database. This phase not specified trial is sponsored by Virginia Commonwealth University and is currently Terminated. The study focuses on Unspecified Adult Solid Tumor, Protocol Specific. Target enrollment is 8 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.